JR Mackey

895 total citations
14 papers, 485 citations indexed

About

JR Mackey is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, JR Mackey has authored 14 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in JR Mackey's work include Cancer Treatment and Pharmacology (5 papers), Cancer survivorship and care (3 papers) and Cardiac Imaging and Diagnostics (3 papers). JR Mackey is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Cancer survivorship and care (3 papers) and Cardiac Imaging and Diagnostics (3 papers). JR Mackey collaborates with scholars based in Canada, United States and France. JR Mackey's co-authors include Carlos M. Galmarini, Charles Dumontet, Valerie Cwik, Loree Larratt, Sapan S. Desai, Jones Lw, Glen Clack, M. Campone, Edith Pituskin and R.A. Hannon and has published in prestigious journals such as Cancer Research, Leukemia and Bone Marrow Transplantation.

In The Last Decade

JR Mackey

14 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
JR Mackey Canada	6	220	157	96	86	66	14	485
Emeline Cros France	12	385 1.8×	191 1.2×	85 0.9×	213 2.5×	105 1.6×	13	628
Kamran Gharehbaghi Austria	13	328 1.5×	127 0.8×	67 0.7×	213 2.5×	127 1.9×	25	675
Konrad Pillwein Austria	15	269 1.2×	80 0.5×	87 0.9×	38 0.4×	62 0.9×	28	481
G Pizzorno United States	13	301 1.4×	199 1.3×	45 0.5×	45 0.5×	21 0.3×	19	558
Joan A. Esplin United States	10	288 1.3×	181 1.2×	27 0.3×	79 0.9×	63 1.0×	13	775
Lanier H. Ayscue United States	10	148 0.7×	97 0.6×	26 0.3×	107 1.2×	87 1.3×	11	396
Tatjana Spasokoukotskaja Sweden	11	299 1.4×	154 1.0×	92 1.0×	79 0.9×	212 3.2×	17	516
A L Jackman United Kingdom	9	302 1.4×	230 1.5×	57 0.6×	43 0.5×	28 0.4×	12	515
Paul H. Fischer United States	12	289 1.3×	259 1.6×	105 1.1×	20 0.2×	17 0.3×	26	540
Francis Relouzat France	9	187 0.8×	216 1.4×	49 0.5×	308 3.6×	125 1.9×	20	910

Countries citing papers authored by JR Mackey

Since Specialization

Citations

This map shows the geographic impact of JR Mackey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JR Mackey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JR Mackey more than expected).

Fields of papers citing papers by JR Mackey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JR Mackey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JR Mackey. The network helps show where JR Mackey may publish in the future.

Co-authorship network of co-authors of JR Mackey

This figure shows the co-authorship network connecting the top 25 collaborators of JR Mackey. A scholar is included among the top collaborators of JR Mackey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JR Mackey. JR Mackey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kirkham, Amy A., Lingfan Xu, Julie R. White, et al.. (2019). Abstract P1-03-07: Breast cancer diagnosis is associated with relative left ventricular hypertrophy. Cancer Research. 79(4_Supplement). P1–3. 1 indexed citations

Spera, Gonzalo, Rodrigo Fresco, Hoki Fung, et al.. (2017). Abstract P6-16-02: Beta-adrenergic receptor blockers (BB) and increased progression free survival (PFS) in patients with advanced triple negative breast cancer (TNBC): A retrospective analysis of the ROSE/TRIO012 study. Cancer Research. 77(4_Supplement). P6–16. 1 indexed citations

Damaraju, Sambasivarao, Karen A. Gelmon, José Á. García-Sáenz, et al.. (2016). Abstract P1-13-03: Genome wide association study (GWAS) of genetic variants associated with docetaxel toxicity in the ROSE/TRIO-012 trial. Cancer Research. 76(4_Supplement). P1–13. 1 indexed citations

Pituskin, Edith, JR Mackey, Sheri L. Koshman, et al.. (2016). Abstract PD5-03: Prophylactic beta blockade preserves left ventricular ejection fraction in HER2-overexpresssing breast cancer patients receiving trastuzumab: Primary results of the MANTICORE randomized controlled trial. Cancer Research. 76(4_Supplement). PD5–3. 8 indexed citations

Pituskin, Edith, et al.. (2016). Abstract S1-05: Prophylactic beta blockade preserves left ventricular ejection fraction in HER2-overexpresssing breast cancer patients receiving trastuzumab: Primary results of the MANTICORE randomized controlled trial. Cancer Research. 76(4_Supplement). S1–5. 6 indexed citations

Mackey, JR, Karen A. Gelmon, Yumiko Yasui, et al.. (2013). Abstract PD2-6: Exercise dose and type effects in breast cancer patients receiving chemotherapy: A randomized trial. Cancer Research. 73(24_Supplement). PD2–6. 2 indexed citations

Mackey, JR, Nicole McCarthy, Semiglazov Vf, et al.. (2013). Abstract S5-04: Primary results of ROSE/TRIO-12, a randomized placebo controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer. Cancer Research. 73(24_Supplement). S5–4. 4 indexed citations

Gelmon, Karen A., et al.. (2013). Abstract P4-08-01: Effects of exercise during adjuvant chemotherapy on clinical outcomes in early stage breast cancer. Cancer Research. 73(24_Supplement). P4–8. 2 indexed citations

Fenton, David, et al.. (2010). Abstract PD05-04: The Potential of Using Discordance of Estrogen PET (FES-PET) and Glucose PET (FDG-PET) Scans and Pathologic Characteristics Including HER2 and Ki67 To Predict for Hormone Insensitivity in Women with Metastatic Breast Cancer. Cancer Research. 70(24_Supplement). PD05–4. 2 indexed citations

10.

Damaraju, Sambasivarao, et al.. (2010). Abstract P3-08-04: Germline Copy Number Polymorphisms Associated with Toxicity from Adjuvant Docetaxel. Cancer Research. 70(24_Supplement). P3–8. 3 indexed citations

11.

Poznak, Catherine Van, R.A. Hannon, Glen Clack, et al.. (2009). Managing cancer treatment-induced bone loss: 24-month results from the Study of Anastrozole with the Bisphosphonate RisedronatE (SABRE).. Cancer Research. 69(2_Supplement). 1137–1137. 14 indexed citations

12.

Mackey, JR, et al.. (2001). Coping with cancer: can exercise help?. Rehabilitation Oncology. 19(2). 30–30. 8 indexed citations

13.

Galmarini, Carlos M., JR Mackey, & Charles Dumontet. (2001). Nucleoside analogues: mechanisms of drug resistance and reversal strategies. Leukemia. 15(6). 875–890. 392 indexed citations

14.

Mackey, JR, et al.. (1997). Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplantation. 19(9). 939–942. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact